ReviewJournal of cancer research and clinical oncology2023

Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.

Rodrigo Santiago Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.